Unknown

Dataset Information

Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies.


ABSTRACT:

Purpose

To determine the degree of testing consistency among commercially available diagnostic assays for hereditary hematopoietic malignancies (HHMs).

Methods

Next-generation sequencing assays designed for the diagnosis of HHMs were studied to determine which genes were sequenced, their ability to detect variant types relevant for HHMs, and clinical-grade characteristics such as price, turnaround time, and tissue types accepted.

Results

Commercial assays varied in price (USD 250-4702), number of genes sequenced (12-73), and average turnaround time (14-42 days). A number of nongermline tissue types were accepted despite the tests being designed for germline diagnostic purposes. Multiple genes with well-characterized roles in HHM pathogenesis were omitted from more tha

SUBMITTER: Roloff GW 

PROVIDER: S-EPMC9299956 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature